Granulomatous hypersensitivity to Schistosoma mansoni egg antigens in human schistosomiasis. II. In vitro granuloma modulation induced by polyclonal idiotypic antibodies.
We have previously reported on Id/anti-Id-receptor interactions in clinical human schistosomiasis. These findings support a hypothesis that anti-SEA cross-reactive Id develop in some patients during the course of a chronic infection and participate in regulation of anti-SEA cellular immune responses. We report here on experiments that extend those observations to the regulation of granulomatous hypersensitivity measured by an in vitro granuloma model. T cells from chronic intestinal schistosomiasis patients were stimulated in vitro with anti-SEA Id and assayed in an autologous in vitro granuloma assay for modulation of granuloma formation. These anti-SEA Id-reactive T cells were capable of regulating autologous in vitro granuloma formation. Both CD4 and CD8 T cells could be activated to regulate granuloma formation. This regulatory activity, initiated with stimulatory anti-SEA idiotypic antibodies, was antigenically specific and was dependent on the presence of intact F(ab')2 Ig molecules. The ability to elicit this regulatory activity appears to be dose dependent and is more easily demonstrated in chronically infected intestinal patients or SEA-sensitized individuals. These data support the hypothesis that anti-SEA cross-reactive Id are important in regulating granulomatous hypersensitivity in chronic intestinal schistosomiasis patients and these cross-reactive Id appear to play a major role in cell-cell interactions that result in the regulation of anti-SEA cellular immune responses.
Centro de Pesquisas Rene Rachou, FIOCRUZ, Belo Horizonte, Brazil.
J C
JC
Parra
G
G
Gazzinelli
A M
AM
Goes
R B
RB
Moyes
R
R
Rocha
D G
DG
Colley
B L
BL
Doughty
D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000276:immunology*; D000909:Antibodies, Helminth / Q000276:immunology; D016525:Antigenic Modulation; D000947:Antigens, Helminth / Q000276:immunology*; D006099:Granuloma / Q000276:immunology; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology*; D007140:Immunoglobulin Fab Fragments / Q000276:immunology; D066298:In Vitro Techniques; D008213:Lymphocyte Activation; D010063:Ovum; D012550:Schistosoma mansoni / Q000276:immunology*; D012555:Schistosomiasis mansoni / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology
D000888:Antibodies, Anti-Idiotypic; D000909:Antibodies, Helminth; D000947:Antigens, Helminth; D007140:Immunoglobulin Fab Fragments